SVAS Biologicals produce high-quality, affordable Liraglutide and Semaglutide which are used in the therapy of type 2 diabetes.

Liraglutide is a recombinant DNA-produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which works effectively when used in combination with diet and exercise in the therapy of type 2 diabetes.

Semaglutide is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain and it is an anti-diabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long term weight management.